Materials and Methods

Apparatus
We used Technicon-recommended methodologies and reagents. For one part of the study, we modified one of our two scs by adding a five-turn mixing coil (part no. 178-G196-01) before and after the pre-dilution cartridge, to assess the effect of additional mixing on precision.
To measure viscosity (five determinations with each specimen) we used a size-75 routine viscometer (no. CFRC; Cannon-Fenske, State College, PA 16801), kept in a constant-temperature water bath at 37 #{176}C. 
Control Sera
Decision level 3 (lot no. C012234, compared with Ortho abnormal in Table 1 ) was shipped by the manufacturer on solid C02-which had sublimed by the time the shipment was received, although the product was still cold to the touch. The product was immediately stored at -20 #{176}C. The manufacturer, queried about the warming of the product, indicated that no damage had occurred and that the product was suitable for use. A second lot of Decision level 3 (lot no. C104033, compared with Omega H in Table 1 ) was obtained with solid CO2 still present in the shipping container and immediately stored at -20 #{176}C. The Decision level 3 was packaged in 20-mL plastic squeeze bottles, which were stored at -20 #{176}C until used in this study, at which point it was kept in a refrigerator at 2 to 8 #{176}C, for no longer than six days.
The two lyophilized control sera studied were Ortho abnormal (lot no. 10T564; Ortho Diagnostic Systems, Inc., Raritan, NJ 08869) and Omega II (lot no. 4822F001B; Hyland Laboratories, Malvern, PA 19355), reconstituted with the diluent supplied by the manufacturers, and according to their instructions.
Procedures
Each control sera was analyzed five times per day for 20 (Decision vs Ortho) or 16 (Decision vs Omega) working days. The control sera were placed in consecutive cups in alternating order for analysis by SMAC.
The effect of carryover and additional mixing on the precision of Decision level 3 was also evaluated. For carryover, Decision level 3 was placed in two consecutive cups and analyzed five times per day for 15 working days. To assessthe effect of additional mixing, one of our two SMAC instruments was modified by adding two five-turn mixing coils and Decision level 3 was analyzed five times per day for 15 working days on both SMAC instruments.
Total imprecision was assessed by calculating the variance and coefficient of variation (CV) for each analyte among the three control materials. The p value for the F ratio (variance for Decision divided by the variance for the lyophilized control material) was obtained by use of pro- 
Results
The variances for the 19 analytes for the Decision level 3 control serum were significantly larger (p < 0.00001, omnibus test) than those obtained with the two lyophilized control sera (Table 1 ). The mean CV and the individual CVs for 17 of 19 analytes were lower with the Ortho abnormal control serum than with Decision ( Table 1) . With the Omega II control serum, the mean CV and the individual CVs of 15 of the 19 analytes were lower than with Decision (Table 1) . No significant difference was found in overall precision for the 19 analytes between the first sample and the second sample of consecutive cups or with and without additional mixing. The viscosity of Decision was more than twice that of the lyophilized control serum and pooled human serum, the relative (to distilled water) viscosities being as follows: pooled human serum, 1.58; Ortho abnormal control serum, 1.80; Omega II control serum, 1.62; and Decision level 3, 3.82.
Discussion
The Decision liquid quality-control serum showed a significantly greater total imprecision than that for two lyophilized control sera assayed in the SMAC. A recent study by George et al. Two additional studies were done in an attempt to identify the cause of the imprecision with Decision control serum. Blanks and Parker (5) reported that the Decision qualitycontrol problems they observed with three analytes for sMAc could be corrected by adding two five-turn mixing coils to the predilution cartridge, one preceding and one following the cartridge. We did not find that this same modification to SMAC significantly altered precision for Decision level 3. In addition, when we compared the results for the analysis of two consecutive specimens of Decision level 3 to evaluate carryover, we found no significant differences in precision. Evidently, mixing and carryover are not significant factors for the imprecision noted with the Decision level 3 control serum.
The above-noted greater viscosity of Decision may contribute to the larger variance when it is used in a hydraulic sera require reconstitution, but they afford greater precision than the liquid Decision control serum with SMAC, hence we recommend use of the former with the SMAC.
We thank Dr. David Alling for valuable help with the statistical analysis.
